Immunogenicity and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 Season Southern Hemisphere) in Adults 18 Years of Age and Above
PHASE3
The purpose of this study is to evaluate the safety and immunogenicity of G...
A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK2321138A) Manufactured Using a New Process in Adults and Children
PHASE3
The purpose of this trial is to demonstrate the acceptable safety profile a...
Evaluation of the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine Influsplit⢠Tetra (Fluarix⢠Tetra) (GSK2321138A) When Co-administered With Pneumovax⢠23 in Adults 50 Years of Age and Older
PHASE3
The purpose of this study is to investigate the immunogenicity and safety w...
Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older
PHASE3
The purpose of this study is to assess immunogenicity, reactogenicity and s...